Patient characteristics and haemodynamics at baseline. Clinical characteristics, haemodynamic values of the pulmonary and general circulation, and arterial and mixed venous oxygen saturation before treatment with epoprostenol
| Patient | Age (years) | Sex | NYHA | PAPm (mm Hg) |
APm (mm Hg) | PCWP (mm Hg) | CI (l/min/m2) | PVRI (U/m2) | Sa o 2 (%) | Sv o 2 (%) |
| Before inhalation of NO | ||||||||||
| 1 | 25 | M | III | 63 | 87 | 10 | 2.7 | 5.7 | 93 | 62 |
| 2 | 49 | F | III | 61 | 71 | 7 | 2.6 | 6.4 | 92 | 58 |
| 3 | 50 | M | IV | 38 | 71 | 10 | 1.1 | 6.4 | 92 | 52 |
| 4 | 33 | F | III | 44 | 74 | 7 | 2.6 | 8.2 | 91 | 66 |
| 5 | 38 | F | III | 53 | 73 | 8 | 2.9 | 9.3 | 94 | 63 |
| 6 | 42 | F | III | 53 | 72 | 10 | 2.5 | 9.3 | 93 | 53 |
| 7 | 58 | F | III | 61 | 75 | 8 | 2.8 | 6.8 | 92 | 62 |
| Mean (SD) | 53 (9) | 75 (6) | 9 (1) | 2.4 (0.6) | 7.5 (1.5) | 92 (1) | 60 (5) | |||
| After inhalation of NO | ||||||||||
| 1 | 69 | 74 | 14 | 2.9 | 5.9 | 93 | 71 | |||
| 2 | 60 | 85 | 9 | 2.7 | 7.5 | 95 | 64 | |||
| 3 | 40 | 69 | 10 | 1.1 | 6.7 | 94 | 55 | |||
| 4 | 44 | 74 | 10 | 3.0 | 5.9 | 94 | 67 | |||
| 5 | 55 | 73 | 8 | 2.9 | 7.3 | 93 | 67 | |||
| 6 | 62 | 75 | 9 | 2.7 | 9.2 | 93 | 62 | |||
| 7 | 57 | 74 | 8 | 2.5 | 7.1 | 94 | 63 | |||
| Mean (SD) | 55 (10) | 75 (5) | 10 (2) | 2.5 (0.7) | 7.1 (1.1) | 94 (1) | 64 (5) | |||
APm, mean arterial pressure; CI, cardiac index; NYHA, New York Heart Association functional class; PAPm, mean pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; PVRI, pulmonary vascular resistance index; Sao2, systemic arterial oxygen saturation; Svo 2, mixed venous oxygen saturation.